Postoperative Changes in Skeletal Muscle Mass Predict Survival of Patients With Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy
- 10 August 2016
- journal article
- research article
- Published by Elsevier BV in Clinical Genitourinary Cancer
- Vol. 15 (2), e229-e238
- https://doi.org/10.1016/j.clgc.2016.08.004
Abstract
No abstract availableFunding Information
- Clinical Research Fund of the Tokyo Metropolitan Government (H260301002)
This publication has 28 references indexed in Scilit:
- Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinomaBritish Journal of Surgery, 2013
- Improved survival in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy in the era of targeted therapyInternational Journal of Clinical Oncology, 2013
- Pazopanib versus Sunitinib in Metastatic Renal-Cell CarcinomaThe New England Journal of Medicine, 2013
- Sarcopenia as a Prognostic Factor among Patients with Stage III MelanomaAnnals of Surgical Oncology, 2011
- Definition and classification of cancer cachexia: an international consensusThe Lancet Oncology, 2011
- Phase‐II trial of combination treatment of interferon‐α, cimetidine, cyclooxygenase‐2 inhibitor and renin‐angiotensin‐system inhibitor (I‐CCA therapy) for advanced renal cell carcinomaCancer Science, 2010
- Prognosis of Japanese Metastatic Renal Cell Carcinoma Patients in the Cytokine Era: A Cooperative Group Report of 1463 PatientsEuropean Urology, 2010
- Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter StudyJournal of Clinical Oncology, 2009
- The Clavien-Dindo Classification of Surgical ComplicationsAnnals of Surgery, 2009
- Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional imageJournal of Applied Physiology, 2004